Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: Dermacyd Femina Pocket BR (Lactic Acid)
- Registration Number
- NCT00794612
- Lead Sponsor
- Sanofi
- Brief Summary
The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Dermacyd Femina Pocket BR (Lactic Acid) Dermacyd Femina Pocket BR (Lactic Acid)
- Primary Outcome Measures
Name Time Method Absence of irritation From the start to the end of the study Good acceptability From the start to the end of the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil
Sanofi-Aventis Administrative Office🇧🇷Sao Paulo, Brazil